Skip to content
SPECIFICTION
Get listed

AwareID vs Neurotechnology VeriLook

AwareID

developer.aware.com

Neurotechnology VeriLook

neurotechnology.com

Side by side

FigureAwareIDNeurotechnology VeriLook
Price from——
Free plan——
Free trial—Yes
Open source——
WebYes—
Windows—Yes
macOS—Yes
Linux—Yes
iOSYesYes
AndroidYesYes
APIYes—
Self-hosted—Yes
Plans published03
Spec score · Biometric Authentication Software7.9 (#20)8.2 (#12)
HeadquartersBurlington, Massachusetts, United StatesVilnius, Lithuania
SupportThe developer site provides a forum for users.The product page says customer support is free.

Plans

AwareID

No plans published.

AwareID pricing →

Neurotechnology VeriLook

  • VeriLook 2025.2 Standard SDK€339, paid once
  • VeriLook 2025.2 Extended SDK€859, paid once
  • VeriLook 2025.2 Enterprise licensePriced on request

Neurotechnology VeriLook pricing →

In their own words

AwareID

AwareID has no write-up on Specifiction yet; its figures are above.

Visit developer.aware.com

Neurotechnology VeriLook

Neurotechnology VeriLook is a self-hosted face-recognition SDK for developers and integrators building stand-alone or client-server applications. It supports 1-to-1 face verification and 1-to-many identification, and can process multiple faces in live video and still images. The maker gives detection times of 0.01–0.86 seconds, depending on settings. Liveness detection has passive and active modes and is stated to comply with ISO 30107-3. The maker also says partially occluded faces, including masked faces, can be recognized, and near-infrared images can be matched with visible-light images. Optional tools include age estimation, gender classification, facial attributes, 68 facial feature points, face morph detection and image quality assessment. Samples and tutorials are listed for C/C++, C#, VB.NET, Java and Python. It runs on Windows, Linux, macOS, iOS and Android. The Standard SDK costs €339, paid once and the Extended SDK €859, paid once; both are perpetual development licenses, with component licenses required for each deployment device. A 30-day trial is available.

Visit neurotechnology.com